filgotinib

Gilead Sciences Inc.'s Best Moves in 2016
Motley Fool
Thu, 12/15/16 - 12:00 pm
Gilead Sciences
NASH
hepatitis C
filgotinib
Galapagos
Gilead Takes Lead on Crohn's over AbbVie
Investopedia
Mon, 11/28/16 - 11:33 pm
Gilead Sciences
AbbVie
Crohn's Disease
Galapagos
filgotinib
ABT-494
Will Gilead (GILD) Stock Be Helped by Positive Crohn's Drug Results?
TheStreet.com
Mon, 09/26/16 - 03:25 pm
Gilead Sciences
Crohn's Disease
filgotinib
Galapagos
Gilead tackles a big PhIII program for blockbuster hopeful filgotinib
Endpoints
Tue, 08/23/16 - 05:45 pm
Gilead Sciences
filgotinib
rheumatoid arthritis
Gilead Takes a Page Out of Celgene's Playbook
Motley Fool
Sat, 01/23/16 - 12:51 pm
Gilead Sciences
Celgene
Galapagos
M&A
filgotinib
Can Gilead Sciences Save Key Pipeline Blockbusters from Rivals?
Bidness, ETC
Sat, 01/2/16 - 10:16 am
Gilead Sciences
simtuzumab
NASH
JAK inhibitors
filgotinib
Gilead joins Pfizer and Eli Lilly in JAK Race
Bidness, ETC
Sun, 12/27/15 - 10:24 am
Gilead Sciences
JAK inhibitors
Pfizer
Eli Lilly
filgotinib
Galapagos
Xeljanz
baricitinib
Are Gilead Sciences, AstraZeneca Deals a Threat to AbbVie?
Bidness, ETC
Sun, 12/20/15 - 04:45 pm
Gilead Sciences
AstraZeneca
AbbVie
filgotinib
Acerta Pharma
Galapagos
Belgium's Galapagos signs $2 bln deal with U.S. company Gilead
Yahoo/Reuters
Thu, 12/17/15 - 09:50 am
Belgium
Galapagos
Gilead Sciences
filgotinib
R&D
Galapagos' inflammation drug comes through in Crohn's with Phase III in sight
Fierce Biotech
Tue, 12/8/15 - 10:54 pm
Galapagos
Crohn's Disease
filgotinib
Why Four Months Is Worth $350m To AbbVie And Filgotinib
Seeking Alpha
Fri, 08/21/15 - 05:19 pm
AbbVie
filgotinib
FDA
review vouchers
priority review
Galapagos starts timer on AbbVie buy-in decision with posting of final data
Fierce Biotech
Fri, 08/14/15 - 09:20 am
Galapagos
AbbVie
JAK inhibitors
rheumatoid arthritis
filgotinib

Pages